Speaker:

Varun Pulakanti, MD, Neurology staff member, Geisinger - has nothing to disclose.
 

Learning Objectives: 

At the conclusion of this session, the participant should be able to: 
  • Review how hyperlipidemia causes vascular disease.
  • Discuss the potential pitfalls and misconceptions of how we measure and qualify hyperlipidemia.
  • Present current guidelines for the diagnosis and management of hyperlipidemia.
  • Discuss the truths and fallacies behind statin use and adverse side effects.
  • Delve into the evidence for second-line lipid-lowering therapies.
  • Conclude by presenting a potential algorithm for the workup and management of hyperlipidemia.

Disclosure of Relevant Financial Relationships with/without Commercial Interests:

The Planning Committee consisting of Dana Vanino, DO, Joy Hill, RN, Karen Tillotson, PA-C and Ali Brandau have no identified disclosures. 
 

CE Committee Member/Content Reviewers have nothing to disclose.

Any/All relevant financial relationships have been mitigated. 

Content Disclosure: 

This presentation/content is HIPPA compliant. 
 

Commerical Support for this Session

None
Session date: 
04/03/2024 - 12:00pm to 1:00pm EDT
Location: 
Geisinger Medical Center
United States
See map: Google Maps
Add to calendar: 
  • 1.00 AAPA Category I CME
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC
  • 1.00 Participation Credit

Please login or register to take this course.